Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |